Martin-Varillas, J. L.Calvo-Rio, V.Sanchez-Bilbao, L.Gonzalez-Mazon, I.Torre-Salaberri, I.Garcia Martos, A.Sanchez-Andrade, A.Garcia-Aparicio, A.De Dios-Jimenez Aberasturi, J.Urruticoechea-Arana, A.Maiz, O.Gonzalez, R. VerozGarcia-Valle, A.Rodriguez Montero, S.Miguelez, R.Jovani, V.Hernandez-Garfella, M.Conesa, A.Martinez Gonzalez, O.Rubio Munoz, P.Atienza-Mateo, B.Gonzalez-Gay, M. A.Blanco, R.2025-01-072025-01-072020-06-010003-4967https://hdl.handle.net/10668/27144enCERTOLIZUMAB THERAPY IN REFRACTORY UVEITIS DUE TO IMMUNE-MEDIATED INFLAMMATORY DISEASES (IMID). MULTICENTER STUDY OF 39 PATIENTSconference outputopen access10.1136/annrheumdis-2020-eular.63671468-2060https://ard.bmj.com/content/annrheumdis/79/Suppl_1/384.2.full.pdf555905001155